ATE105192T1 - Methode fuer die kontrolle von chronischer atmungskrankheit und nekrotischer enteritis bei voegeln. - Google Patents

Methode fuer die kontrolle von chronischer atmungskrankheit und nekrotischer enteritis bei voegeln.

Info

Publication number
ATE105192T1
ATE105192T1 AT8888116050T AT88116050T ATE105192T1 AT E105192 T1 ATE105192 T1 AT E105192T1 AT 8888116050 T AT8888116050 T AT 8888116050T AT 88116050 T AT88116050 T AT 88116050T AT E105192 T1 ATE105192 T1 AT E105192T1
Authority
AT
Austria
Prior art keywords
alpha
respiratory disease
birds
chronic respiratory
necrotic enteritis
Prior art date
Application number
AT8888116050T
Other languages
English (en)
Inventor
Guy Thomas Carter
Michael Greenstein
Joseph Jacob Goodman
Donald Bruce Borders
William Michael Maiese
Raymond Thomas Testa
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE105192T1 publication Critical patent/ATE105192T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/195Antibiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
AT8888116050T 1987-10-29 1988-09-29 Methode fuer die kontrolle von chronischer atmungskrankheit und nekrotischer enteritis bei voegeln. ATE105192T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11490087A 1987-10-29 1987-10-29
EP88116050A EP0313846B1 (de) 1987-10-29 1988-09-29 Methode für die Kontrolle von chronischer Atmungskrankheit und nekrotischer Enteritis bei Vögeln

Publications (1)

Publication Number Publication Date
ATE105192T1 true ATE105192T1 (de) 1994-05-15

Family

ID=22358115

Family Applications (1)

Application Number Title Priority Date Filing Date
AT8888116050T ATE105192T1 (de) 1987-10-29 1988-09-29 Methode fuer die kontrolle von chronischer atmungskrankheit und nekrotischer enteritis bei voegeln.

Country Status (11)

Country Link
EP (1) EP0313846B1 (de)
JP (1) JP2522528B2 (de)
AT (1) ATE105192T1 (de)
AU (2) AU2448688A (de)
DE (1) DE3889417T2 (de)
DK (1) DK601788A (de)
HU (1) HUT48682A (de)
IE (1) IE64520B1 (de)
IL (1) IL87889A0 (de)
NZ (1) NZ226645A (de)
ZA (1) ZA888122B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN115095A0 (en) * 1995-02-15 1995-03-09 Butt, Henry Lawrence Analysis of and compositions and methods for the treatment of disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5774090A (en) * 1980-10-27 1982-05-10 Shionogi & Co Ltd Novel beta-galactosidase inhibitor, gt-2558, its derivative, and production
DE3778225D1 (de) * 1986-06-30 1992-05-21 American Cyanamid Co Antibiotikum ll-e19020 alpha und beta.

Also Published As

Publication number Publication date
DK601788D0 (da) 1988-10-28
AU1382292A (en) 1992-05-28
IE64520B1 (en) 1995-08-09
JPH01149731A (ja) 1989-06-12
DE3889417D1 (de) 1994-06-09
DK601788A (da) 1989-04-30
IL87889A0 (en) 1989-03-31
AU2448688A (en) 1989-05-04
IE883260L (en) 1989-04-29
DE3889417T2 (de) 1994-12-01
ZA888122B (en) 1990-06-27
HUT48682A (en) 1989-06-28
AU637947B2 (en) 1993-06-10
EP0313846A2 (de) 1989-05-03
NZ226645A (en) 1992-01-29
JP2522528B2 (ja) 1996-08-07
EP0313846A3 (en) 1990-08-01
EP0313846B1 (de) 1994-05-04

Similar Documents

Publication Publication Date Title
DE69127470D1 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
MX9203543A (es) Medicamento.
IT1241996B (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
CA2093806A1 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
DE3879873D1 (de) Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
NO902800D0 (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
GR3025488T3 (en) Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions
NL960024I2 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus besmette patiënten.
EP0376251A3 (en) An anticoagulant substance obtained from urine
ES2061826T3 (es) Un procedimiento de preparacion de derivados n-2,3-butadienil triaminoalcanos.
EP0328924A3 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische Anwendungen
SE8500996D0 (sv) Method of treatment
DE68927055T2 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
ATE105192T1 (de) Methode fuer die kontrolle von chronischer atmungskrankheit und nekrotischer enteritis bei voegeln.
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
EP0304897A3 (de) Mittel zur Immunisierung des menschlichen Körpers bei HIV-Infektionen
DE69008282D1 (de) Kaffeesäure-Derivate, deren Verwendung für medizinische Behandlungen und diese enthaltende pharmazeutische Zusammensetzungen.
KR930703003A (ko) 피부질환치료용 제약 조성물